Adaptive Biotechnologies Stock Price - ADPT

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
After Hours
Last Trade
Last: $ 30.13 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Adaptive Biotechnologies Corporation ADPT NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.24 0.8% 30.13 31.235 29.16 29.78 29.89 17:49:03
Bid Price Ask Price Spread Spread % News
30.00 30.30 0.30 0.99% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,783 475,651 $ 30.30 $ 14,411,146 605,136 26.63 - 55.1203
Last Trade Time Type Quantity Stock Price Currency
16:30:44 94 $ 30.13 USD

Adaptive Biotechnologies Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.74B 124.29M $ 13.22M -0.44 -83.70 118.48M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 16.00 4.70%

more financials information »

Adaptive Biotechnologies News

Loading Messages....

Latest ADPT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADPT Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week30.0731.23526.6328.4923495k0.060.20%
1 Month39.8641.526.6332.8457646k-9.73-24.41%
3 Months40.355.120326.6338.1548487k-10.17-25.24%
6 Months39.0155.120326.6338.6193607k-8.88-22.76%
1 Year39.0155.120326.6338.6193607k-8.88-22.76%
3 Years39.0155.120326.6338.6193607k-8.88-22.76%
5 Years39.0155.120326.6338.6193607k-8.88-22.76%

Adaptive Biotechnologies Description

Adaptive Biotechnologies Corp is a a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.


Your Recent History
NASDAQ
ADPT
Adaptive B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.